| Document and Entity Information | Apr. 30, 2024 |
| Cover [Abstract] | |
| Amendment Flag | false |
| Entity Central Index Key | 0001817229 |
| Document Type | 8-K |
| Document Period End Date | Apr. 30, 2024 |
| Entity Registrant Name | Vor Biopharma Inc. |
| Entity Incorporation State Country Code | DE |
| Entity File Number | 001-39979 |
| Entity Tax Identification Number | 81-1591163 |
| Entity Address, Address Line One | 100 Cambridgepark |
| Entity Address, Address Line Two | Drive |
| Entity Address, Address Line Three | Suite 101 |
| Entity Address, City or Town | Cambridge |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 02140 |
| City Area Code | (617) |
| Local Phone Number | 655-6580 |
| Written Communications | false |
| Soliciting Material | false |
| Pre Commencement Tender Offer | false |
| Pre Commencement Issuer Tender Offer | false |
| Security 12b Title | Common Stock, $0.0001 par value per share |
| Trading Symbol | VOR |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | false |
